ALTEROLA BIOTECH INC. ACQUIRES ABTI PHARMA LTD
Alterola Biotech Inc. acquires ABTI Pharma Ltd as part of its strategic move into the cannabinoid medicines sector. Liverpool, UK, (July 23rd, 2021) – Alterola Biotech Inc. (OTC: ABTI), today announces the acquisition of ABTI Pharma Ltd, a company developing novel cannabinoid, cannabinoid-like, and non-cannabinoid pharmaceutical medicines, active pharmaceutical ingredientsRead More →